Status:
UNKNOWN
The Effect of Colon Cancer on Muscle Gene Expression, Body Composition, Muscle Function, and Muscle Metabolism
Lead Sponsor:
Wageningen University
Collaborating Sponsors:
Gelderse Vallei Hospital
Top Institute Food and Nutrition
Conditions:
Cachexia; Cancer
Eligibility:
All Genders
Brief Summary
Rationale: Cancer cachexia is a complex metabolic syndrome characterized by clinically relevant loss of muscle mass with or without loss of fat mass. To determine how treatment methods can be most eff...
Eligibility Criteria
Inclusion
- CC patients:
- In order to be eligible to participate in this study, a subject must meet all of the following inclusion criteria:
- Diagnosed with primary colon cancer (30) or liver metastases due to colon cancer(10)
- Eligible for a primary tumor or liver metastases resection procedure
- Controls:
- Eligible for an inguinal hernia repair (♂, 10) or an abdominal hysterectomy (♀, 5)
Exclusion
- CC patients:
- A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Having had chemotherapy or an operational procedure of the abdomen in the past 6 months
- Suffering from malabsorption
- Controls:
- Having had treatment for previous or current tumors
Key Trial Info
Start Date :
February 24 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT03789136
Start Date
February 24 2017
End Date
December 31 2022
Last Update
June 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gelderse Vallei Hospital
Ede, Gelderland, Netherlands, 6716 RP